FDA Inspection 1294356 — BioLife Plasma Services LP

BioLife Plasma Services LP — FEI 3021985827

The FDA completed an inspection of BioLife Plasma Services LP on December 5, 2025 in Fort Worth, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 5, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Worth, TX (United States)

Citations

IDCFRDescription
4121 CFR 606.40(a)(1)Provide space for examination
905021 CFR 600.11(a)Work areas
9821 CFR 606.100(c)Thorough investigations